Study shows convalescent plasma therapy effective at reducing mortality from COVID-19

A new study shows that convalescent plasma treatments, or plasma donated from recovered patients, reduces the risk of death among critically ill COVID-19 patients. Researchers from Houston Methodist Medical Center found that transfusing the plasma, with its anti-COVID-19 antibodies, within 72 hours after hospitalization proved most effective at decreasing the mortality rate. Tens of thousands of Americans have already received convalescent plasma transfusions, with only minimal side effects reported.

Related Post
Related Post